ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

Phase II Study of Docetaxel and Trametinib in Patients with KRAS Mutation Positive Recurrent Non-Small Cell Lung Cancer (NSCLC; SWOG S1507, NCT-02642042).

Shirish M Gadgeel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.